Loading your page…
Each register with its number of medicines and a few of them.
FDA · 3 medicines
Anvisa · 1 medicine · Historical list
Health Canada · 1 medicine
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 1 medicine
AIFA · 1 medicine
CBG-MEB · 1 medicine
PHARMAC · 1 medicine
TFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
10 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Rifabutin | United States | 150MG | capsule | Marketed | I3 Pharms |
| Mycobutin | United States | 150MG | capsule | Marketed | Pfizer |
| Mycobutin | Italy | Capsula rigida | Authorised | Pfizer Italia S.R.L. | |
| Mycobutin | Canada | 150 MG | Capsule | Marketed | Pfizer Canada Ulc |
| Mycobutin, capsules 150 mg | Netherlands | Capsule, hard | Authorised | Pfizer B.V. | |
| TaliciaCombination | United States | 250MG; 10MG BASE; 12.5MG | capsule, delayed release | Marketed | Talicia Holdings |
| Ansatipin 150 MG Cápsulas Duras | Spain | 150 mg | cápsula dura | Marketed | Binesa 2002 S.L. |
| Mycobutin | New Zealand | Cap 150 mg | Funded | ||
| Mycobutin | Brazil | Cancelled | Laboratórios Pfizer Ltda | ||
| Ributin Capsule 150mg | Taiwan | 膠囊劑 | Expired | 微確藥品有限公司 |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, FDA, Health Canada, PHARMAC and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
